News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

PARI Partner Project News

Partner Project News

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

PARI Publication

PARI Publication

A Novel Human Factors Approach for a New Platform-Based, Breath-Triggered Nebuliser

Published

December 9, 2011

Category

PARI Publications

A Novel Nebuliser for the Simultaneous Administration of siRNA and Supplemental Oxygen for RSV in Infants.

A Novel Nebuliser for the Simultaneous Administration of siRNA and Supplemental Oxygen for RSV in Infants.

Published

August 1, 2011

Category

Publications

Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.

Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.

Published

July 6, 2011

Category

PARI Publications

Objective Evaluation of Adherence to Inhaled Liposomal Cyclosporin Therapy for Lung Transplant Patients in a Clinical Trial.

Objective Evaluation of Adherence to Inhaled Liposomal Cyclosporin Therapy for Lung Transplant Patients in a Clinical Trial.

Published

March 1, 2011

Category

Publications

A Comparison of Amount and Speed of Deposition Between the PARI LC STAR® Jet Nebulizer and an Investigational eFlow® Nebulizer.

A Comparison of Amount and Speed of Deposition Between the PARI LC STAR® Jet Nebulizer and an Investigational eFlow® Nebulizer.

Published

March 17, 2010

Categories

PARI Publications
Publications

Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.

Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.

Contact us

eFlow-partneringpari.com

Two smiling men in a blue circle. The central man wears glasses and a light blue shirt. The man on the left has a beard and a blue patterned shirt.

PARI Business Development Team